“In Brief: Laboratory and clinical monitoring requirements for JAK inhibitors” (2023) Canadian Dermatology Today, 4(1), pp. 20–22. Available at: https://canadiandermatologytoday.com/article/view/4-1-veillette (Accessed: 19 March 2026).